[The immunomodulating properties of a diphtheria bacterial vaccine in in vitro experiments]

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Lymphocytes sensitized with Corynebacterium diphtheriae antigens are crucial for understanding immune responses.
• Existing immune-modulating preparations include diphtheria toxoid, staphylococcal toxoid, staphylococcal vaccine, and levamisole.

Purpose of the Study:

• To evaluate the immunomodulatory effects of the novel diphtheria bacterial vaccine, Codivac.
• To compare Codivac's efficacy with other established immunostimulatory and immunocorrective agents.

Main Methods:

• Utilized lymphocytes sensitized with Corynebacterium diphtheriae antigens from carriers and convalescents.
• Administered Codivac and compared its effects on T-lymphocyte levels against diphtheria toxoid, staphylococcal toxoid, staphylococcal vaccine, and levamisole.

Main Results:

• Codivac demonstrated a more direct effect on modulating T-lymphocyte levels compared to other preparations.
• The vaccine's effect was dependent on the initial T-lymphocyte levels in patients.
• Codivac exhibited unique immunomodulatory properties distinct from conventional treatments.

Conclusions:

• Codivac presents a novel therapeutic option for modulating T-lymphocyte responses.
• The findings support the potential use of Codivac in immunostimulation and immunocorrective therapy.
• Further research into Codivac's mechanisms and applications in immunotherapy is warranted.